Literature DB >> 8286217

The role of apoptosis in cell killing by cisplatin: a flow cytometric study.

M G Ormerod1, R M Orr, J H Peacock.   

Abstract

Cell killing of L1210 cells by cisplatin has been studied using flow cytometry and DNA gel electrophoresis. Ten hours after a supralethal dose of drug (100 microM), extensive apoptosis was induced. Cells were also susceptible to the induction of apoptosis by nutritional deprivation, for example by incubation in arginine-deficient medium. After treatment in full medium with doses of drug in the range 1-10 microM, cells experienced a slow-down in S-phase transit followed by a G2 block. Cells either overcame the G2 block and continued to cycle or enlarged and eventually died. There was no evidence to suggest that cells dying from the G2 block underwent apoptosis. The data were consistent with a dual mechanism of cell death-higher doses of drug led to rapid death through apoptosis; lower doses led to death at later times resulting from failure to overcome a block in G2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286217      PMCID: PMC1968755          DOI: 10.1038/bjc.1994.14

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.

Authors:  M A Barry; C A Behnke; A Eastman
Journal:  Biochem Pharmacol       Date:  1990-11-15       Impact factor: 5.858

Review 2.  Apoptosis: mechanisms and roles in pathology.

Authors:  M J Arends; A H Wyllie
Journal:  Int Rev Exp Pathol       Date:  1991

3.  Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry.

Authors:  W G Telford; L E King; P J Fraker
Journal:  Cell Prolif       Date:  1991-09       Impact factor: 6.831

4.  Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes.

Authors:  P R Walker; C Smith; T Youdale; J Leblanc; J F Whitfield; M Sikorska
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

5.  Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.

Authors:  T Fujikane; T Shimizu; T Tsuji; S Ishida; Y Ohsaki; S Onodera
Journal:  Cytometry       Date:  1989-11

6.  Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin.

Authors:  C M Sorenson; M A Barry; A Eastman
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

7.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

8.  Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.

Authors:  C M Sorenson; A Eastman
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

9.  Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores.

Authors:  G Rodriguez-Tarduchy; M Collins; A López-Rivas
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

Review 10.  Drug-target interactions: only the first step in the commitment to a programmed cell death?

Authors:  C Dive; J A Hickman
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more
  31 in total

1.  Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine.

Authors:  Behrooz Niknafs
Journal:  Iran Biomed J       Date:  2011

2.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.

Authors:  D B Zamble; T Jacks; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Cytokinetic effects of cisplatin on diverse human head and neck carcinomas in vitro: dependence on the tumor sensitivity to cisplatin.

Authors:  M C Jäckel; R Tausch-Treml; P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.

Authors:  Murugan Kalimutho; Antonella Minutolo; Sandro Grelli; Giorgio Federici; Sergio Bernardini
Journal:  Acta Pharmacol Sin       Date:  2011-09-19       Impact factor: 6.150

5.  Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.

Authors:  Marina Martínez-Carmona; Quy P Ho; Jérémy Morand; Ana García; Enrique Ortega; Luiza C S Erthal; Eduardo Ruiz-Hernandez; M Dolores Santana; José Ruiz; Maria Vallet-Regí; Yurii K Gun'ko
Journal:  Inorg Chem       Date:  2020-07-06       Impact factor: 5.165

6.  SUMOylation is developmentally regulated and required for cell pairing during conjugation in Tetrahymena thermophila.

Authors:  Amjad M Nasir; Qianyi Yang; Douglas L Chalker; James D Forney
Journal:  Eukaryot Cell       Date:  2014-12-19

7.  [Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].

Authors:  Shuangyan Ye; Sisi Zeng; Mengqiu Huang; Jianping Chen; Xi Chen; Pengfei Xu; Qianli Wang; Wenwen Gao; Bingsheng Yang; Bingtao Hao; Wenhuan Huang; Qiuzhen Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

8.  Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin.

Authors:  Tracy M Neher; Diane Bodenmiller; Richard W Fitch; Shadia I Jalal; John J Turchi
Journal:  Mol Cancer Ther       Date:  2011-08-16       Impact factor: 6.261

9.  Cytochemical study of role of alpha-d-mannose- and beta-d-galactose-containing glycoproteins in apoptosis.

Authors:  R O Bilyy; V O Antonyuk; R S Stoika
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

10.  cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines.

Authors:  M G Ormerod; C O'Neill; D Robertson; L R Kelland; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.